CORRECTION OF AGGREGATIVE FUNCTION OF THE TROMBOCYTES IN ARTERIAL HYPERTENSION PATIENTS WITH METABOLIC SYNDROM UNDER THE INFLUENCE OF SIMVASTATINE
The application of simvastatine in arterial hypertension patients with metabolic syndrom corrects dislipoproteidemia, peroxidation syndrome, thrombocyte formation and optimized the thrombocyte hemostasis. Simvastatine inhibits decreased adhesive and aggregative function of thrombocytes. For stabiliz...
Main Authors: | N. J. Gromnazky, J. N. Medvedev, B. M. Golikov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2003-12-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/1871 |
Similar Items
-
Increased intravascular platelet activity in metabolic syndrome patients, and its correction by simvastatin treatment
by: N. I. Gromnatsky, et al.
Published: (2004-12-01) -
AGGREGATION PROPERTIES OF BLOOD CELLS AND VASCULAR CONTROL OVER THEM IN PATIENTS WITH ARTERIAL HYPERTENSION AND DYSLIPIDEMIA
by: I. N. Medvedev, et al.
Published: (2015-04-01) -
PLATELET HEMOSTASIS DYNAMICS IN SIMVASTATINTREATED PATIENTS WITH ARTERIAL HYPERTENSION AND DYSLIPIDEMIA
by: I. N. Medvedev, et al.
Published: (2010-02-01) -
STATE CONTROL OF THE VASCULAR WALL TO ANTIAGGREGATIVE BY NEUTROPHILS IN PATIENTS ARTERIAL HYPERTENSION WITH DYSLIPIDEMIA PATIENTS TREATED WITH SIMVASTATIN
by: I. N. Medvedev, et al.
Published: (2013-03-01) -
Dry Powder Formulation of Simvastatin Nanoparticles for Potential Application in Pulmonary Arterial Hypertension
by: Shalaleh Zendehdel Baher, et al.
Published: (2022-04-01)